Acute StrokeNCT07355881
mSOAR and Early Mortality in Acute Stroke
An observational study of Acute Stroke, run by Sohag University at 1 site in Egypt.
Trial summary
This observational study aims to evaluate the predictive accuracy of the Modified SOAR score for early mortality in patients with acute stroke. Adult patients presenting with acute stroke at Sohag University Hospitals will be included. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Acute Stroke
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Nov 2025to 1 Jul 2026
- How long will I take part?
- 7 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: The study population includes patients diagnosed with acute stroke who are admitted to Sohag University Hospitals. Patients must present within 24 hours of symptom onset and provide informed consent. This cohort will include both male and female patients, and patients with complete medical records necessary for calculating the Modified SOAR score.
Who may be able to join
- Patients diagnosed with acute stroke
- Patients admitted to Sohag University Hospitals
- Patients who underwent clinical evaluation
- Patients who provided informed consent
Who cannot join
- Patients with transient ischemic attack (TIA)
- Patients with orthopedic conditions
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Modified SOAR Score as a Predictor of Early Mortality in Hospitalized Patients With Acute Stroke
This observational study aims to evaluate the predictive accuracy of the Modified SOAR score for early mortality in patients with acute stroke. Adult patients presenting with acute stroke at Sohag University Hospitals will be included. Data on clinical presentation, medical history, and relevant laboratory investigations will be collected. The study will follow patients during their hospital stay to determine outcomes related to early mortality. The findings will help improve early risk stratification and management of acute stroke patients.
- Conditions
- Acute Stroke
- Being tested
- No Intervention (Observational Study)
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No Intervention (Observational Study)Other
Participants will receive standard of care only. No study-specific intervention is applied.
| Study group | Role | What they receive |
|---|---|---|
| Acute Stroke Patients | Not described Receives: Other: No Intervention (Observational Study) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Early Mortality
Assessment of early mortality in patients with acute stroke during the follow-up period.
Measured: 7days
Early mortality
Assessment of early mortality in patients with acute stroke during the first 7 days of hospital admission. Patients will be monitored from hospital admission until 7 days or until death, whichever occurs first. The Modified SOAR score will be recorded for each patient at admission to evaluate its predictive accuracy for early mortality within this period.
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jan 2026
- Study start1 Nov 2025
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
- Target duration
- 7 Days
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kareman Mohamed Abdelaziz, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07355881
- Sponsor's protocol ID
- Soh-Med--25-12-16MS
- Status last verified
- Jan 2026
- First submitted
- 12 Jan 2026
- Last updated
- 28 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Modified SOAR Score as a Predictor of Early Mortality in Hospitalized Patients With Acute Stroke
- ClinicalTrials.gov ID
- NCT07355881
- Acronym / sponsor ID
- Soh-Med--25-12-16MS
- Conditions
- Acute Stroke
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Nov 2025 (actual)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Jul 2026 (estimated)
- First posted
- 21 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational study aims to evaluate the predictive accuracy of the Modified SOAR score for early mortality in patients with acute stroke. Adult patients presenting with acute stroke at Sohag University Hospitals will be included. Data on clinical presentation, medical history, and relevant laboratory investigations will be collected. The study will follow patients during their hospital stay to determine outcomes related to early mortality. The findings will help improve early risk stratification and management of acute stroke patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 7 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Acute Stroke Patients | – | Other: No Intervention (Observational Study) |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population includes patients diagnosed with acute stroke who are admitted to Sohag University Hospitals. Patients must present within 24 hours of symptom onset and provide informed consent. This cohort will include both male and female patients, and patients with complete medical records necessary for calculating the Modified SOAR score.
Key inclusion criteria (4 listed)
- Patients diagnosed with acute stroke
- Patients admitted to Sohag University Hospitals
- Patients who underwent clinical evaluation
- Patients who provided informed consent
Key exclusion criteria (2 listed)
- Patients with transient ischemic attack (TIA)
- Patients with orthopedic conditions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No Intervention (Observational Study)Participants will receive standard of care only. No study-specific intervention is applied. | Other | Acute Stroke Patients |
Primary outcome
Early Mortality
Time frame: 7days
Assessment of early mortality in patients with acute stroke during the follow-up period.
Early mortality
Time frame: 7 days
Assessment of early mortality in patients with acute stroke during the first 7 days of hospital admission. Patients will be monitored from hospital admission until 7 days or until death, whichever occurs first. The Modified SOAR score will be recorded for each patient at admission to evaluate its predictive accuracy for early mortality within this period.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Acute Stroke
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Stroke, Acute
RecruitingObservational study
Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
Aphasia, Stroke
RecruitingObservational study
Natural History of Stroke: Cause and Development
Brain Disease, Ischemic Attack, Transient
Not yet recruiting
Prehospital Response and Emergency Stroke Transport Optimisation
Acute Ischemic Stroke
Active, not recruitingObservational study
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
Stroke, Acute, Gait, Hemiplegic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Stroke, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kareman Mohamed, MD (01146569365 ext. 01028478260, karimanmohammed21@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Early Mortality (time frame: 7days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.